G1 Therapeutics, Inc. (GTHX)
Total Valuation
GTHX has a market cap or net worth of $208.83 million. The enterprise value is $107.56 million.
| Market Cap | 208.83M |
| Enterprise Value | 107.56M |
Important Dates
The next earnings date is Wednesday, August 3, 2022, after market close.
| Estimated Earnings Date | Aug 3, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
GTHX has 42.71 million shares outstanding. The number of shares has increased by 4.88% in one year.
| Shares Outstanding | 42.71M |
| Shares Change (YoY) | +4.88% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | 9.10% |
| Owned by Institutions (%) | 68.26% |
| Float | 35.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.64 |
| PB Ratio | 2.09 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.96, with a Debt / Equity ratio of 0.82.
| Current Ratio | 5.96 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -107.70%, which is considered low. The company has a ROIC of -258.00%.
| Return on Equity (ROE) | -107.70% |
| Return on Assets (ROA) | -69.00% |
| Return on Capital (ROIC) | -258.00% |
| Revenue Per Employee | $163,243 |
| Profits Per Employee | -$1.16M |
| Employee Count | 148 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.53 |
Taxes
In the past 12 months, GTHX has paid $787,000 in taxes.
| Income Tax | 787,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.77% in the last 52 weeks. The beta is 2.03, so GTHX's price volatility has been higher than the market average.
| Beta (1Y) | 2.03 |
| 52-Week Price Change | -77.77% |
| 50-Day Moving Average | 4.75 |
| 200-Day Moving Average | 7.85 |
| Average Volume (30 Days) | 1,115,214 |
Short Selling Information
The latest short interest is 7.75 million, so 18.14% of the outstanding shares have been sold short.
| Short Interest | 7.75M |
| Short % of Shares Out | 18.14% |
| Short % of Float | 21.58% |
| Short Ratio (days to cover) | 6.62 |
Income Statement
In the last 12 months, GTHX had revenue of $24.16 million and -171.10 million in losses. Earnings per share was -$4.03.
| Revenue | 24.16M |
| Gross Profit | 21.72M |
| Operating Income | -163.70M |
| Pretax Income | -170.32M |
| Net Income | -171.10M |
| EBITDA | -163.67M |
| EBIT | -164.13M |
| Earnings Per Share (EPS) | -$4.03 |
Balance Sheet
The company has $183.40 million in cash and $82.12 million in debt, giving a net cash position of $101.27 million or $2.37 per share.
| Cash & Cash Equivalents | 183.40M |
| Total Debt | 82.12M |
| Net Cash | 101.27M |
| Net Cash Per Share | $2.37 |
| Book Value | 100.13M |
| Book Value Per Share | 2.34 |
| Working Capital | 173.35M |
Cash Flow
| Operating Cash Flow | -143.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -143.41M |
| FCF Per Share | n/a |
Margins
Gross margin is 89.89%, with operating and profit margins of -677.58% and -708.20%.
| Gross Margin | 89.89% |
| Operating Margin | -677.58% |
| Pretax Margin | -704.95% |
| Profit Margin | -708.20% |
| EBITDA Margin | -677.43% |
| EBIT Margin | -679.35% |
| FCF Margin | -593.59% |
Dividends & Yields
GTHX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -81.93% |
| FCF Yield | -68.67% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.88% |
| Shareholder Yield | -4.88% |
Analyst Forecast
The average price target for GTHX is $40.29, which is 723.93% higher than the current price. The consensus rating is "Buy".
| Price Target | $40.29 |
| Price Target Difference | 723.93% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |